Alloimmunization remains a significant complication of transfusion and has been associated with multiple factors, including inflammation, an important pathophysiologic mechanism in sickle cell disease (SCD). We explored whether alloimmunization is associated with disease severity in SCD
Contains fulltext : 166311.pdf (publisher's version ) (Open Access)Red cell alloan...
Introduction - Sickle cell anemia is characterized by chronic hemolytic anemia, the main treatment b...
Vasoocclusion leads to pain, chronic organ damage, and a decreased life expectancy in patients with ...
Alloimmunization remains a significant complication of transfusion and has been associated with mult...
Red blood cell (RBC) alloimmunization is a significant clinical complication of sickle cell disease ...
Delayed hemolytic transfusion reactions (DHTR) are potentially life-threatening complications observ...
Red blood cell (RBC) alloimmunization is a major complication of transfusion therapy in sickle cell ...
The reason for the difference in susceptibility to red blood cell (RBC) alloimmunization among patie...
Background & objectives: Sickle cell disease (SCD) patients require red cell transfusion during diff...
Sickle cell disease (SCD) is the most common monogenic disorder in sub-Saharan Africa (SSA). Blood t...
Background: RBC alloimmunization remains a significant problem for many patients with SCD. To reduce...
Blood transfusions are indicated for some acute complications of sickle cell disease (SCD). To chara...
Delayed haemolytic transfusion reaction (DHTR) is a potentially life-threatening complication of red...
Acute pain is the hallmark of sickle cell disease and is the most common cause of hospital admission...
Sickle Cell Anemia is a debilitating genetic condition effecting nearly a million people in the Unit...
Contains fulltext : 166311.pdf (publisher's version ) (Open Access)Red cell alloan...
Introduction - Sickle cell anemia is characterized by chronic hemolytic anemia, the main treatment b...
Vasoocclusion leads to pain, chronic organ damage, and a decreased life expectancy in patients with ...
Alloimmunization remains a significant complication of transfusion and has been associated with mult...
Red blood cell (RBC) alloimmunization is a significant clinical complication of sickle cell disease ...
Delayed hemolytic transfusion reactions (DHTR) are potentially life-threatening complications observ...
Red blood cell (RBC) alloimmunization is a major complication of transfusion therapy in sickle cell ...
The reason for the difference in susceptibility to red blood cell (RBC) alloimmunization among patie...
Background & objectives: Sickle cell disease (SCD) patients require red cell transfusion during diff...
Sickle cell disease (SCD) is the most common monogenic disorder in sub-Saharan Africa (SSA). Blood t...
Background: RBC alloimmunization remains a significant problem for many patients with SCD. To reduce...
Blood transfusions are indicated for some acute complications of sickle cell disease (SCD). To chara...
Delayed haemolytic transfusion reaction (DHTR) is a potentially life-threatening complication of red...
Acute pain is the hallmark of sickle cell disease and is the most common cause of hospital admission...
Sickle Cell Anemia is a debilitating genetic condition effecting nearly a million people in the Unit...
Contains fulltext : 166311.pdf (publisher's version ) (Open Access)Red cell alloan...
Introduction - Sickle cell anemia is characterized by chronic hemolytic anemia, the main treatment b...
Vasoocclusion leads to pain, chronic organ damage, and a decreased life expectancy in patients with ...